TAM
ARCT icon

Tocqueville Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Tocqueville Asset Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,600
Closed -$83.4K – 550
2025
Q4 		$83.4K Sell
13,600
-12,900
-49% -$139K ﹤0.01% 573
2025
Q3 		$488K Sell
26,500
-2,200
-8% -$35.3K 0.01% 435
2025
Q2 		$373K Buy
28,700
+5,300
+23% +$62.7K 0.01% 450
2025
Q1 		$248K Buy
23,400
+1,000
+4% +$15.9K ﹤0.01% 480
2024
Q4 		$380K Buy
22,400
+6,700
+43% +$126K 0.01% 453
2024
Q3 		$364K Buy
15,700
+1,700
+12% +$36.4K 0.01% 442
2024
Q2 		$341K Sell
14,000
-500
-3% -$15.2K 0.01% 444
2024
Q1 		$490K Sell
14,500
-1,400
-9% -$49.6K 0.01% 412
2023
Q4 		$501K Buy
15,900
+600
+4% +$14.3K 0.01% 401
2023
Q3 		$391K Buy
15,300
+2,200
+17% +$67.8K 0.01% 421
2023
Q2 		$376K Sell
13,100
-5,100
-28% -$139K 0.01% 435
2023
Q1 		$436K Buy
+18,200
New +$327K 0.01% 425
2020
Q2 		– Sell
-10,450
Closed -$142K – 653
2020
Q1 		$142K Buy
+10,450
New +$134K ﹤0.01% 610

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tocqueville Asset Management's ARCT Position: Q1 2026 in Review

Tocqueville Asset Management sold out of Arcturus Therapeutics (ARCT) in Q1 2026, closing a stake of 13,600 shares — an estimated $83.4K sold.

Tocqueville Asset Management first reported a position in ARCT in Q1 2020 and held it in 13 quarters. The position peaked at $501K in Q4 2023. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

  • Tocqueville Asset Management reported no remaining Arcturus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Tocqueville Asset Management sold 13,600 Arcturus Therapeutics shares in Q1 2026, an estimated $83.4K.
  • Tocqueville Asset Management first reported a position in Arcturus Therapeutics in Q1 2020 and held it in 13 quarters.
  • Tocqueville Asset Management's Arcturus Therapeutics position peaked at $501K in Q4 2023.
  • 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on Tocqueville Asset Management's 13F filing for Q1 2026, filed 12 May 2026.